Journal Article10.1016/S0140-6736(89)92914-0
Gender and survival in neuroblastoma.
5
About: This article is published in The Lancet. The article was published on 22 Apr 1989.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Incidence and prognostic role of the ocular manifestations of neuroblastoma in children.
TL;DR: In this cohort, approximately 1 in 6 patients with neuroblastoma had ocular manifestations, but only 3% presented with only ocular findings, while a favorable prognosis was associated with opsoclonus, female sex, and younger age at diagnosis were associated with a unfavorable prognosis.
18
•Dissertation
Molecular genetic analysis of a constitutional chromosome translocation in a patient with ganglioneuroblastoma
Antony Michalski
- 01 Jan 1994
TL;DR: The breakpoint junction fragment of a constitutional t(l;13 )(q22 ;q l2 ) from DG, a 5 year old boy with ganglioneuroblastoma, is isolated to see whether a gene critical to neural development has been disrupted.
4
Association between CYP2B6 genetic variability and cyclophosphamide therapy in pediatric patients with neuroblastoma.
TL;DR: The aim of the study was to reveal the contribution of pharmacogenetic variability in CYP2B6 and CYP2C19 to the treatment efficacy and cyclophosphamide-induced side effects in pediatric neuroblastoma patients under cyclophosphamide therapy.
2
Improved Survival of Children With Neuroblastoma Between 1979 and 2005: A Report of the Italian Neuroblastoma Registry
Riccardo Haupt,Alberto Garaventa,Claudio Gambini,Stefano Parodi,Giuliana Cangemi,Fiorina Casale,Elisabetta Viscardi,Maurizio Bianchi,Arcangelo Prete,Alessandro Jenkner,Roberto Luksch,Andrea Di Cataldo,Claudio Favre,Paolo D'Angelo,Giulio Andrea Zanazzo,Giampaolo Arcamone,Gian Carlo Izzi,Anna Rita Gigliotti,Guido Pastore,Bruno De Bernardi +19 more
TL;DR: The outcome of children with neuroblastoma has progressively improved and long-term survivors bear a significant risk of second malignant neoplasm, and OS improved significantly over time in stage 1 and 3 patients.
Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992.
TL;DR: This ENSG Survey provides secure data for future comparisons with new prognostic factors and treatment programmes and gender had no significant effect on outcome after stage and age were accounted for.
References
Prognostic factors in neuroblastoma
Audrey E. Evans,Giulio J. D'Angio,Kathleen J. Propert,James G. Anderson,Hie-Won L. Hann,Hie-Won L. Hann +5 more
TL;DR: The results suggest that combinations of age, stage, serum ferritin, and histologic type may be able to define two populations: favorable with 80% + 2‐year survival and unfavorable with less than 20%.
302
Epidemiological investigations on neuroblastomas in Denmark 1943-1980
TL;DR: During the period 1943-1980 a significant increase in the incidence of neuroblastoma was seen in Denmark and the increase appears to be continuing, and the incidence in the first year of life has not yet reached the level of the USA.
36
An analysis of neuroblastoma at a single institution
Patrick R.M. Thomas,Patrick R.M. Thomas,Jeannette Y. Lee,Barbara Fineberg,Aly Razek,Carlos A. Perez,Vita J. Land,Teresa J. Vietti +7 more
TL;DR: The overwhelming influence of factors unrelated to treatment in determining the prognosis of neuroblastoma is confirmed and stage, histology, age at diagnosis, and site of primary tumor are independent prognostic variables.
29
Neuroblastoma: Recent Developments in Assessment and Management
J. Pritchard,J. Kemshead +1 more
TL;DR: “Good-prognosis�”, “intermediate-proGNosis” and “bad-pro prognosis” patients can now be defined; unfortunately, the latter predominate and give the tumour its overall unsavoury reputation.
16